Yaky Yanay
2009
In 2009, Yaky Yanay earned a total compensation of $319.3K as Chief Financial Officer at Pluristem Therapeutics, a 31% decrease compared to previous year.
Compensation breakdown
| Salary | $140,974 |
|---|---|
| Stock Awards | $159,057 |
| Other | $19,220 |
| Total | $319,251 |
Yanay received $159.1K in stock awards, accounting for 50% of the total pay in 2009.
Yanay also received $141K in salary and $19.2K in other compensation.
Rankings
In 2009, Yaky Yanay's compensation ranked 8,221st out of 9,885 executives tracked by ExecPay. In other words, Yanay earned more than 16.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,221 out of 9,885 | 17th |
Division Manufacturing | 3,087 out of 3,690 | 16th |
Major group Chemicals And Allied Products | 716 out of 866 | 17th |
Industry group Drugs | 515 out of 638 | 19th |
Industry Biological Products, Except Diagnostic Substances | 94 out of 133 | 29th |
Source: SEC filing on November 23, 2009.
Yanay's colleagues
We found one more compensation record of an executive who worked with Yaky Yanay at Pluristem Therapeutics in 2009.
2009
Zami Aberman
Pluristem Therapeutics
Chief Executive Officer
News
Pluristem Therapeutics CEO Yaky Yanay's 2023 pay jumps 111% to $2.7M
May 1, 2024
Pluristem Therapeutics CEO Yaky Yanay's 2022 pay falls 86% to $1.3M
February 27, 2023
Pluristem Therapeutics Chairman Zami Aberman's 2020 pay falls 54% to $501K
April 8, 2021
Pluristem Therapeutics Chairman Zami Aberman's 2019 pay jumps 85% to $1.1M
May 20, 2020
Pluristem Therapeutics CEO Zami Aberman's 2018 pay falls 83% to $593K
April 25, 2019